Cohn Robbins (NYSE:CRHC) announced over the weekend that it has jointly terminated its $9.3 billion combination with lottery operator Allwyn.
The move comes at the very end of the process for Cohn, whose shareholders approved the transaction on September 7. Cohn Robbins extended its transaction deadline from September 11 to December 11 on the same day, which appeared at the time to simply provide more cushion to clear regulatory hurdles and close the deal.
But, near-term market woes got in the way. The SPAC’s management noted in its release that “we have witnessed a pronounced negative turn in market psychology, and just last week the market suffered its worst day since June 2020, with the sharply negative trend continuing this week.”
Nonetheless, the team’s disappointment in the result is palpable in the release, noting that Allwyn “received strong indications of support during recent meetings with investors” who “offered commitments of almost $700m to support the combination“.
The deal included a minimum cash condition of $850 million and Cohn Robbins brought a $353 million PIPE and €323 million ($311 million) convertible note into the deal. But, it also saw 91% of shares redeemed at its completion vote.
Cohn Robbins will now “consider in due course” whether to seek an alternative business combination with less than three months left on the clock to do so. The Allwyn combination would have been the largest deal announced in 2022 to close by far.
The largest deal that has reached completion following a 2022 announcement is Social Capital Suvretta III’s $1.8 billion tie-up with ProKidney (NASDAQ:PROK). Goldenstone’s (NASDAQ:GDST) pending $3.6 billion merger with Roxe Holding is now the largest deal the working to close that was announced in 2022.
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...